| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/10428190500513595 |
| P698 | PubMed publication ID | 16840201 |
| P50 | author | Alessandro Isidori | Q46389798 |
| P2093 | author name string | M Brunori | |
| P Leoni | |||
| G Visani | |||
| G Martinelli | |||
| A Olivieri | |||
| P P Piccaluga | |||
| G Pomponio | |||
| M Malagola | |||
| G Sparaventi | |||
| D Capelli | |||
| P2860 | cites work | Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission | Q28290182 |
| Finding and applying evidence during clinical rounds: the "evidence cart". | Q31988167 | ||
| Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas | Q33361455 | ||
| The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients | Q34288377 | ||
| The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial | Q34525604 | ||
| Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial | Q34533140 | ||
| Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Par | Q34746103 | ||
| Purine nucleoside analogues in the treatment of myleoid leukemias | Q35104351 | ||
| Consolidation therapy with autologous bone marrow transplantation in adults with acute myeloid leukemia: a meta-analysis | Q35622255 | ||
| Fludarabine, arabinosyl cytosine and idarubicin (FLAI) for remission induction in poor-risk acute myeloid leukemia | Q43653729 | ||
| Comparison of idarubicin + ara-C-, fludarabine + ara-C-, and topotecan + ara-C-based regimens in treatment of newly diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation, or refractory anemia with excess blasts | Q43819619 | ||
| Comparison of allogeneic stem cell transplantation, high-dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia | Q44375011 | ||
| The randomized controlled trial gets a middle-aged checkup | Q44420303 | ||
| A randomized trial of high-versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabine | Q44948875 | ||
| Hematopoietic stem cell transplantation for hematological malignancies in Europe. | Q47908471 | ||
| Analysis of the National Institutes of Health Medicare coverage assessment | Q68584645 | ||
| Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission: a prospective controlled trial | Q69510193 | ||
| Dose intensification in acute myeloid leukaemia: greater effectiveness at lower cost. Principal report of the Medical Research Council's AML9 study. MRC Leukaemia in Adults Working Party | Q71397114 | ||
| Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Ad | Q72377470 | ||
| Evidence-based medicine and treatment choices | Q73107161 | ||
| Evidence-based medicine | Q73430749 | ||
| Evidence based practice | Q73547435 | ||
| No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) | Q74260794 | ||
| Meta-analysis of autologous bone marrow transplantation versus chemotherapy in adult patients with acute myeloid leukemia in first remission | Q80034606 | ||
| Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission: a prospective randomized Dutch-Belgian Haemato-Oncology Co-operative Group (H | Q81162601 | ||
| P433 | issue | 6 | |
| P921 | main subject | acute myeloid leukemia | Q264118 |
| adult acute myeloid leukemia | Q53673331 | ||
| P304 | page(s) | 1091-1102 | |
| P577 | publication date | 2006-06-01 | |
| P1433 | published in | Leukemia & Lymphoma | Q6534493 |
| P1476 | title | Consolidation therapy for adult acute myeloid leukemia: a systematic analysis according to evidence based medicine | |
| P478 | volume | 47 |
| Q34608688 | Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials |
| Q38208953 | Optimal therapy for adult patients with acute myeloid leukemia in first complete remission |
| Q34634662 | Prediction of post-remission survival in acute myeloid leukaemia: a post-hoc analysis of the AML96 trial |
Search more.